Abiomed Inc. (NSDQ:ABMD) and Opsens (TSX:OPS) inked a deal to incorporate fiberoptic blood pressure measurement into Abiomed’s Impella heart pump.
Abiomed will use fiberoptic sensor technology made by Opsens to allow its tiny heart pump, designed to help the heart during cardiac procedures, to measure blood pressure within the heart. The Impella is threaded into the heart through arteries via a catheter.
The Danvers, Mass.-based company said the Opsens sensor, which is designed to provide longer-term accuracy and reliability than competing sensors, will eventually be used to help automate the Impella’s deployment.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.